[HTML][HTML] Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis
M Rafei, E Birman, K Forner, J Galipeau - Molecular Therapy, 2009 - cell.com
The use of allogeneic" universal donor" mesenchymal stromal cells (MSCs) may be a
substantial clinical convenience for treatment of autoimmune ailments such as multiple …
substantial clinical convenience for treatment of autoimmune ailments such as multiple …
Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis
M Rafei, E Birman, K Forner… - Molecular therapy: the …, 2009 - pubmed.ncbi.nlm.nih.gov
The use of allogeneic" universal donor" mesenchymal stromal cells (MSCs) may be a
substantial clinical convenience for treatment of autoimmune ailments such as multiple …
substantial clinical convenience for treatment of autoimmune ailments such as multiple …
[HTML][HTML] Allogeneic Mesenchymal Stem Cells for Treatment of Experimental Autoimmune Encephalomyelitis
M Rafei, E Birman, K Forner… - Molecular Therapy: the …, 2009 - ncbi.nlm.nih.gov
The use of allogeneic “universal donor” mesenchymal stromal cells (MSCs) may be a
substantial clinical convenience for treatment of autoimmune ailments such as multiple …
substantial clinical convenience for treatment of autoimmune ailments such as multiple …
[PDF][PDF] Allogeneic Mesenchymal Stem Cells for Treatment of Experimental Autoimmune Encephalomyelitis
M Rafei, E Birman, K Forner, J Galipeau - Molecular Therapy, 2009 - researchgate.net
Mesenchymal stromal cells (MSCs) possess clinical potential for the treatment of many
ailments, 1–6 and are the object of numerous early phase human clinical trials. One of the …
ailments, 1–6 and are the object of numerous early phase human clinical trials. One of the …
[PDF][PDF] Allogeneic Mesenchymal Stem Cells for Treatment of Experimental Autoimmune Encephalomyelitis
M Rafei, E Birman, K Forner, J Galipeau - Molecular Therapy, 2009 - cyberleninka.org
Mesenchymal stromal cells (MSCs) possess clinical potential for the treatment of many
ailments, 1–6 and are the object of numerous early phase human clinical trials. One of the …
ailments, 1–6 and are the object of numerous early phase human clinical trials. One of the …
Allogeneic Mesenchymal Stem Cells for Treatment of Experimental Autoimmune Encephalomyelitis.
M Rafei, E Birman, K Forner… - Molecular Therapy, 2009 - search.ebscohost.com
The use of allogeneic “universal donor” mesenchymal stromal cells (MSCs) may be a
substantial clinical convenience for treatment of autoimmune ailments such as multiple …
substantial clinical convenience for treatment of autoimmune ailments such as multiple …
Allogeneic Mesenchymal Stem Cells for Treatment of Experimental Autoimmune Encephalomyelitis
M Rafei, E Birman, K Forner, J Galipeau - Molecular Therapy, 2009 - search.proquest.com
The use of allogeneic" universal donor" mesenchymal stromal cells (MSCs) may be a
substantial clinical convenience for treatment of autoimmune ailments such as multiple …
substantial clinical convenience for treatment of autoimmune ailments such as multiple …
[引用][C] Allogeneic Mesenchymal Stem Cells for Treatment of Experimental Autoimmune Encephalomyelitis
M Rafei, E Birman, K Forner, J Galipeau - Molecular Therapy, 2009 - cir.nii.ac.jp
Allogeneic Mesenchymal Stem Cells for Treatment of Experimental Autoimmune
Encephalomyelitis | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲ恁縖サイニィ] 詳細へ …
Encephalomyelitis | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲ恁縖サイニィ] 詳細へ …
[HTML][HTML] Allogeneic Mesenchymal Stem Cells for Treatment of Experimental Autoimmune Encephalomyelitis
M Rafei, E Birman, K Forner, J Galipeau - Molecular Therapy, 2009 - Elsevier
The use of allogeneic “universal donor” mesenchymal stromal cells (MSCs) may be a
substantial clinical convenience for treatment of autoimmune ailments such as multiple …
substantial clinical convenience for treatment of autoimmune ailments such as multiple …
Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis.
M Rafei, E Birman, K Forner… - Molecular Therapy: the …, 2009 - europepmc.org
The use of allogeneic “universal donor” mesenchymal stromal cells (MSCs) may be a
substantial clinical convenience for treatment of autoimmune ailments such as multiple …
substantial clinical convenience for treatment of autoimmune ailments such as multiple …